|
|
News Breaks | | | | March 8, 2013 | | 13:56 EDT |  | UTHR | United Therapeutics price target raised to $75 from $65 at Argus
Argus increased its price target on United Therapeutics after the company reported higher than expected Q4 EPS. The firm continues to believe that the company will generate strong long-term growth, and it maintains a Buy rating. | |
|
News For UTHR From The Last 14 Days Check below for free stories on UTHR the last two weeks. |
|
|
| May 15, 2013 | | 12:37 EDT |  | UTHR | United Therapeutics downgraded to Hold from Buy at Standpoint Research
 Subscribe for More Information | |
|
|
|
|
|
|
